This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mihaylova, V. T. Articles by Kupfer, G. M. Search for Related Content PubMed PubMed Citation Articles by Mihaylova, V. T. Articles by Kupfer, G. M.

Human T-Cell Leukemia Virus I Tax Protein Sensitizes p53-Mutant Cells to DNA Damage

Departments of ¹ Microbiology and ² Pediatrics, University of Virginia Health System, Charlottesville, Virginia; ³ Department of Microbiology, Eastern Virginia Medical School, Norfolk, Virginia; and ⁴ Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut

Requests for reprints: Gary M. Kupfer, LMP 2074, Division of Pediatric Hematology-Oncology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520. Phone: 203-785-4640; Fax: 203-737-2227; E-mail: gary.kupfer{at}yale.edu.

Key Words: Chemosensitization • hHTLV-I Tax1 • p53

Mutations in p53 are a common cause of resistance of cancers to standard chemotherapy and, thus, treatment failure. Reports have shown that Tax, a human T-cell leukemia virus type I encoded protein that has been associated with genomic instability and perturbation of transcription and cell cycle, sensitizes HeLa cells to UV treatment. The extent to which Tax can sensitize cells and the mechanism by which it exerts its effect are unknown. In this study, we show that Tax sensitizes p53-mutant cells to a broad range of DNA-damaging agents, including mitomycin C, a bifunctional alkylator, etoposide, a topoisomerase II drug, and UV light, but not ionizing radiation, a double-strand break agent, or vinblastine, a tubulin poison. Tax caused hypersensitivity in all p53-deleted cell lines and several, but not all, mutant-expressed p53–containing cell lines, while unexpectedly being protective in p53 wild-type (wt) cells. The effect observed in p53-deleted lines could be reversed for this by transfection of wt p53. We also show that Tax activates a p53-independent proapoptotic program through decreased expression of the retinoblastoma protein and subsequent increased E2F1 expression. The expression of several proapoptotic proteins was also induced by Tax, including Puma and Noxa, culminating in a substantial increase in Bax dimerization. Our results show that Tax can sensitize p53-mutant cells to DNA damage while protecting p53 wt cells, a side benefit that might result in reduced toxicity in normal cells. Such studies hold the promise of a novel adjunctive therapy that could make cancer chemotherapy more effective. [Cancer Res 2008;68(12):4843–52]